Prospective evaluation of the clinical utility of interferon-γ assay in the differential diagnosis of intestinal tuberculosis and Crohn's disease

Inflammatory Bowel Diseases

Volumn 17, Issue 6, 2011, Pages 1308-1313

  Kim, Beom Jin ^a   Choi, Yong Sung ^b   Jang, Byung Ik ^c   Park, Young Sook ^d   Kim, Won Ho ^e   Kim, You Sun ^f   Jung, Sung Ae ^g   Han, Dong Soo ^h   Kim, Joo Sung ⁱ   Choi, Jai Hyun ^j   Choi, Chang Hwan ^a   Jeen, Yoon Tae ^j   Cheon, Jae Hee ^e   Ye, Byong Duk ^k   Yang, Suk Kyun ^l   Kim, Young Ho ^l  

^a Chung Ang University College of Medicine   (South Korea)

^b Daehang Hospital   (South Korea)

^c Yeungnam University College of Medicine   (South Korea)

^d Eulji University   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

^f Inje University College of Medicine   (South Korea)

^g Ewha Womans University School of Medicine   (South Korea)

^h Hanyang University   (South Korea)

ⁱ Seoul National University   (South Korea)

^j Korea University College of Medicine   (South Korea)

^k University of Ulsan College of Medicine   (South Korea)

^l Sungkyunkwan University   (South Korea)

more..

Author keywords

Crohn's disease; diagnosis; interferon assay; intestinal tuberculosis; tuberculin skin test

Indexed keywords

GAMMA INTERFERON; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; COLONOSCOPY; CROHN DISEASE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; INTESTINE TUBERCULOSIS; KOREA; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTIFERON TB GOLD TEST; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INTERFERON-GAMMA; INTESTINAL DISEASES; LYMPHOCYTES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, GASTROINTESTINAL; YOUNG ADULT;

EID: 79955851324     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21490     Document Type: Article

References (27)

1. Dye C, Scheele S, Dolin P, et al. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999; 282: 677-686.
2. Dye C., Global epidemiology of tuberculosis. Lancet. 2006; 367: 938-940.
3. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003; 163: 1009-1021. (Pubitemid 36548927)
4. Thia KT, Loftus EV Jr, Sandborn WJ, et al. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008; 103: 3167-3182.
5. Jayanthi V, Robinson RJ, Malathi S, et al. Does Crohn's disease need differentiation from tuberculosis ? J Gastroenterol Hepatol. 1996; 11: 183-186. (Pubitemid 26121288)
6. Epstein D, Watermeyer G, Kirsch R., Review article: the diagnosis and management of Crohn's disease in populations with high-risk rates for tuberculosis. Aliment Pharmacol Ther. 2007; 25: 1373-1388. (Pubitemid 46860226)
7. Almadi MA, Ghosh S, Aljebreen AM., Differentiating intestinal tuberculosis from Crohn's disease: a diagnostic challenge. Am J Gastroenterol. 2009; 104: 1003-1012.
8. Mazurek GH, Jereb J, Lobue P, et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep. 2005; 54: 49-55.
9. Kang YA, Lee HW, Yoon HI, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA. 2005; 293: 2756-2761.
10. Lee JY, Choi HJ, Park IN, et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J. 2006; 28: 24-30. (Pubitemid 44914256)
11. Kang YA, Lee HW, Hwang SS, et al. Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest. 2007; 132: 959-965.
12. Yao T, Matsui T, Hiwatashi N., Crohn's disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum. 2000; 43: S85-93.
13. Pulimood AB, Ramakrishna BS, Kurian G, et al. Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn's disease from tuberculosis. Gut. 1999; 45: 537-541. (Pubitemid 29447821)
14. Kirsch R, Pentecost M, Hall Pde M, et al. Role of colonoscopic biopsy in distinguishing between Crohn's disease and intestinal tuberculosis. J Clin Pathol. 2006; 59: 840-844. (Pubitemid 44211746)
15. Theis VS, Rhodes JM., Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease. Aliment Pharmacol Ther. 2008; 27: 19-30. (Pubitemid 350212629)
16. Tubach F, Salmon D, Ravaud P, et al. Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French research axed on tolerance of biotherapies registry. Arthritis Rheum. 2009; 60: 1884-1894.
17. Lee YJ, Yang SK, Byeon JS, et al. Analysis of colonoscopic findings in the differential diagnosis between intestinal tuberculosis and Crohn's disease. Endoscopy. 2006; 38: 592-597. (Pubitemid 43978527)
18. Liu TH, Pan GZ, Chen MZ., Crohn's disease. Clinicopathologic manifestations and differential diagnosis from enterocolonic tuberculosis. Chin Med J (Engl). 1981; 94: 431-440.
19. Kobashi Y, Mouri K, Yagi S, et al. Clinical utility of a T cell-based assay in the diagnosis of extrapulmonary tuberculosis. Respirology. 2009; 14: 276-281.
20. Mazurek GH, Weis SE, Moonan PK, et al. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis. Clin Infect Dis. 2007; 45: 837-845. (Pubitemid 47580374)
21. Dewan PK, Grinsdale J, Kawamura LM., Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis. 2007; 44: 69-73. (Pubitemid 44968987)
22. Nishimura T, Hasegawa N, Mori M, et al. Accuracy of an interferon-gamma release assay to detect active pulmonary and extra-pulmonary tuberculosis. Int J Tuberc Lung Dis. 2008; 12: 269-274. (Pubitemid 351361896)
23. Song KH, Jeon JH, Park WB, et al. Usefulness of the whole-blood interferon-gamma release assay for diagnosis of extrapulmonary tuberculosis. Diagn Microbiol Infect Dis. 2009; 63: 182-187.
24. Katiyar SK, Sampath A, Bihari S, et al. Use of the QuantiFERON-TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis. Int J Tuberc Lung Dis. 2008; 12: 1146-1152.
25. Kim SH, Choi SJ, Kim HB, et al. Diagnostic usefulness of a T-cell based assay for extrapulmonary tuberculosis. Arch Intern Med. 2007; 167: 2255-2259.
26. Akobeng AK., Understanding diagnostic tests 1: sensitivity, specificity and predictive values. Acta Paediatr. 2007; 96: 338-341. (Pubitemid 46439514)
27. Akobeng AK., Understanding diagnostic tests 2: likelihood ratios, pre- and post-test probabilities and their use in clinical practice. Acta Paediatr. 2007; 96: 487-491. (Pubitemid 46466110)